As of Oct 02
| +0.04 / +2.48%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +172.73% increase from the last price of 1.65.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.